| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc. | Chief Medical Officer | Employee Stock Option (Right to Buy) | 343,300 | 02 Feb 2026 | Direct | ||
| Aclaris Therapeutics, Inc. | Chief Medical Officer | Restricted Stock Units | 98,100 | 02 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | 02 Feb 2026 | 2 | $0 | 4 | Chief Medical Officer | 06 Feb 2026, 18:04 |
| ACRS | Aclaris Therapeutics, Inc. | 01 May 2025 | 2 | $0 | 4 | Chief Medical Officer | 05 May 2025, 16:32 |
| ACRS | Aclaris Therapeutics, Inc. | 01 May 2025 | 0 | $0 | 3 | Chief Medical Officer | 05 May 2025, 16:29 |